2025 annual financial data
PharmaCyte Biotech 2025 Operating margin
PharmaCyte Biotech 2025 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -4,377,862 USD and net income was 30,656,050 USD.
Operating cash flow was -2,978,296 USD.
Get free PharmaCyte Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -4,377,862 USD
- Net income
- 30,656,050 USD
- Operating cash flow
- -2,978,296 USD